Skip to main content
. 2022 Feb 18;23(4):128. doi: 10.3892/ol.2022.13248

Figure 6.

Figure 6.

4-AAQB treatment downregulates HMGB1, RAGE and MDR1 protein expression. (A) The expression of HMGB1 and RAGE was analyzed using western blotting. (B and C) Semi-quantification of HMGB1 and RAGE protein levels. (D) The expression of MDR1 was analyzed using western blotting. (E) Semi-quantification of MDR1 protein levels. *P<0.05 vs. the untreated control cells. 4-AAQB, 4-Acetylantroquinonol B; GEMR, gemcitabine-resistant; HMGB1, high mobility group box 1 protein; MDR1, multidrug resistance protein 1; RAGE, receptor for advanced glycation end-products.